Company / Working Capital
Edesa Biotech, Inc. Working Capital History
FY2014-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$10.6M
FY2021
5-year range
$6.4M / $11.5M
FY2017-FY2021
Trend
+61.7%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 7 years, ranging from $6M in FY2017 to $13M in FY2015.
Based on SEC 10-K filings.
$11M in FY2021 with a 5-year CAGR of -1.5%.
Improved from $10M to $11M over the past 3 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- +1.5%
- 5-Year CAGR
- -1.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -1.5%, indicating a declining trend.
- In FY2021, working capital increased 61.7% year-over-year.
- Peak working capital was recorded in FY2015.
- Lowest working capital in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $10.6M | +61.7% |
| FY2020 | $6.6M | -35.3% |
| FY2018 | $10.2M | +57.9% |
| FY2017 | $6.4M | -43.9% |
| FY2016 | $11.5M | -9.3% |
| FY2015 | $12.7M | +0.0% |
| FY2014 | $12.7M | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026